This trial is testing a drug to see if it can raise blood pressure in patients with septic shock who have low blood volume.
- Septic Shock
- Low Blood Volume
1 Primary · 1 Secondary · Reporting Duration: 10 Months
1 Treatment Group
1 of 1
20 Total Participants · 1 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 24 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has this method been federally regulated?
"This treatment received a safety rating of 2. This is due to the fact that it is only in Phase 2 trials, meaning while there is evidence supporting its safety, there are no studies yet which suggest it is an effective intervention." - Anonymous Online Contributor
Are there a lot of hospitals participating in this research project within the state?
"Currently, this study is enrolling patients at Einstine Medical Center in East Norriton, Pennsylvania, Dignity Health in Chandler, Arizona, and Henry Ford Health System in Detroit, Michigan. There are 10 other locations where recruitment is happening." - Anonymous Online Contributor
Is this research still looking for volunteers?
"The listed clinical trial on clinicaltrials.gov is still recruiting patients, with the study having been posted on February 17th, 2020 and edited as recently as October 26th, 2020." - Anonymous Online Contributor
What is the total number of participants in this test?
"In order for this clinical trial to move forward, 20 patients that meet the pre-determined criteria must be recruited. The sponsor, Vivacelle Bio, has chosen various locations across America to conduct the trial; two examples are Einstine Medical Center in East Norriton, Pennsylvania and Dignity Health in Chandler, Arizona." - Anonymous Online Contributor